OptimizeRx to Participate at Bank of America Merrill Lynch Health Care Conference on May 13, 2020

Rhea-AI Summary

OptimizeRx Corp. (Nasdaq: OPRX) will participate in the Bank of America Merrill Lynch Health Care conference from May 12-14, 2020. CEO William Febbo is set to present on May 13 at 3:00 p.m. ET, discussing the company's record Q1 results, its extensive client base including the top 20 pharmaceutical companies, and its role in improving health outcomes via its digital health network, which reaches 60% of the U.S. ambulatory market. The event is exclusive to institutional clients and will feature opportunities for one-on-one meetings.

News Market Reaction – OPRX

-0.28%

1 alert

-0.28% News Effect

On the day this news was published, OPRX declined 0.28%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCHESTER, Mich., May 07, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers and providers, has been invited to participate in the Bank of America Merrill Lynch Health Care conference being held on May 12-14, 2020.

The event is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

OptimizeRx CEO William Febbo is scheduled to present on May 13, 2020, at 3:00 p.m. Eastern time, as well as participate in virtual one-on-one meetings. He will discuss a number of topics, including the company’s record Q1 results, client base that includes world’s Top 20 pharmaceutical companies, and how the company is supporting better health outcomes through its digital health network that now reaches reach 60% of the ambulatory market and patients nationwide.

He will also share insight on the company’s latest acquisition of a powerful digital therapeutics SaaS platform, RMDY Health, used by pharma, payers, medtech companies and medical associations worldwide.

The live presentation will be available at investors.optimizerx.com/events-and-presentations.

The event is for institutional clients of BOA and is by invitation only. To schedule a one-on-one meeting with OptimizeRx, please contact your BOA sales representative. For any questions about OptimizeRx, contact Ron Both of CMA at (949) 432-7557 or submit your request here.

About OptimizeRx®
OptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRx’s network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a provider’s workflow through leading electronic health platforms. OptimizeRx’s fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.

For more information, go to OptimizeRx.com, and follow the company on Twitter and LinkedIn.

Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.

OptimizeRx Contact
Doug Baker, CFO
Tel (248) 651-6568 x807
dbaker@optimizerx.com

Media Relations Contact
Maira Alejandra, Media Relations Manager
Tel (754) 245-7070
malejandra@optimizerx.com

Investor Relations Contact
Ron Both or Grant Stude
CMA Investor Relations
Tel (949) 432-7557
oprx@cma.team

FAQ

When will OptimizeRx present at the Bank of America conference?

OptimizeRx will present on May 13, 2020, at 3:00 p.m. Eastern time.

What topics will OptimizeRx discuss at the conference?

OptimizeRx will discuss its record Q1 results, client base, and its digital health network.

What percentage of the ambulatory market does OptimizeRx's network reach?

OptimizeRx's digital health network reaches 60% of the U.S. ambulatory market.

Who is the CEO of OptimizeRx?

The CEO of OptimizeRx is William Febbo.

What is the stock symbol for OptimizeRx?

The stock symbol for OptimizeRx is OPRX.

How can investors participate in one-on-one meetings with OptimizeRx?

Investors can arrange one-on-one meetings by contacting their Bank of America sales representative.